Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 700-251-2 | CAS number: 72684-95-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Endpoint summary
Administrative data
Description of key information
The objective of this study was to assess the skin sensitization potential of Mediator SNP (4-hydroxy-3,5-dimethoxybenzonitrile) after repeated topical applications.
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2008-12-17 to 2009-02-03
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.2600 (Skin Sensitisation)
- Deviations:
- no
- GLP compliance:
- yes
- Type of study:
- mouse local lymph node assay (LLNA)
- Specific details on test material used for the study:
- Test Material: Syringonitrile
- Composition of test material, percentage of components: syringonitrile 99.8%
- Expiration date of the lot/batch: May 2010
-Physical description: pale yellow powder
-solubility: soluble in water
-stability: test substance was expected to be stable for the duration of the testing.
methyl-3H Thymidine
Source: Amersham Batch #B512 received on Jan. 28, 2009. The following information related to the characterization of the radioisotope was provided on the product specification sheet.
Specific Activity: 25 Ci/mmol; 925 GBq/mmol
MW: 244
Radioactive concentrations: 37 MBq; 1 mCi/mL
Date of analysis: Nov. 12, 2008
Radiochemical Purity: 95.1% (HPLC)
Thymine content: 0.2%
Exp date: Jan. 28, 2010 - Species:
- mouse
- Strain:
- CBA
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Received from Jackson Labs on Dec. 31, 2008
- Age at study initiation: Preliminary irritation group: young adult (8 weeks)
Test and Native control group: young adult
- Weight at study initiation: 20.6-24.9 grams
- Housing: suspended stainless steel caging with mesh floors or plastic perforated bottom caging which conform to the size recommendations in the most recent Guide for the Care and Use of Laboratory Animals DHEW (NIH). Litter paper was placed beneath the cage and was changed at least three times per week.
- Diet (e.g. ad libitum): Purina Rodent Chow ad libitum
- Water (e.g. ad libitum): filtered tap water was supplied ad libitum by an automatic water dispensing system.
- Acclimation period: 27 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19-24°C
- Humidity (%): 9-32%
- Photoperiod (hrs dark / hrs light):12-hr light/dark cycle - Vehicle:
- dimethylformamide
- Concentration:
- 0, 10%, 25%, 50% in DMF
- No. of animals per dose:
- 5 mice per group per concentration for the main study (total of 5 groups)
For the preliminary study, 3 mice per group (total of 3 groups) - Details on study design:
- In the preliminary screening test, 3 mice were treated with daily application of 25 μL of various dilutions of Mediator SNP to the dorsal of each ear for three consecutive days for signs of irritation and toxicity. On day 6, each site was evaluated for local reactions (edema and erythema). From these results, the concentrations to be tested in the main assay were selected with the maximum concentration equal to a 50% w/w mixture in DMF.
In the main test, groups of 5 mice each were treated with the test material at concentrations of 0, 10, 25% or 50% in DMF to the dorsal surface of each ear for three consecutive days (Days 1, 2, and 3). On day 6 (three days after the third topical application), all mice were injected via the tail vein with 250 μL of phosphate buffered saline containing 3H-methyl thymidine (for a total of 20 μCi per mouse). Five fours following the administration of 3HTdR, all mice were killed and the auricular lymph nodes were drained. The lymph node cells were collected, washed and suspended in appropriate medium. DNA was then precipitated by the addition of 5 mL of 5% trichloroacetic acid (TCA). Following the overnight precipitation of DNA, the tubes were centrifuged and the supernatant discarded. The precipitate was resuspended in TCA and 3HTdR incorporation was measured by β-scintillation counting. A group of 5 mice receiving 25% HCA (alpha-hexylcinnamaldehyde technical) in DMF served as positive control group. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- Statistical analysis was performed when individual lymph nodes were analyzed. Significance was judged at p<0.05. The treated groups and negative vehicle control group were compared using a One-Way Analysis of Variance (ANOVA), followed by comparison of the treated groups to control by Dunnett's t-test for multiple comparisons. Where variances were considered significantly different by Bartlett's test, groups were compared using a non-parametric method (Kruskal-Wallis non parametric analysis of variance followed by Dunn's test) (INSTAT Biostatistics, Graph Pad Software, San Diego, CA).
- Positive control results:
- Well defined erythema was noted in mice from the positive control group. A stimulation index (SI) of greater than 3.0 was not observed in any of the test groups. The positive control (HCA) at 25% produced a dermal sensitization response with SI = 11.57.
- Parameter:
- SI
- Value:
- 2.18
- Test group / Remarks:
- Group 2: 10%
- Parameter:
- SI
- Value:
- 2.02
- Test group / Remarks:
- Group 3: 25%
- Parameter:
- SI
- Value:
- 1.83
- Test group / Remarks:
- Group 4: 50%
- Parameter:
- SI
- Value:
- 11.57
- Test group / Remarks:
- Group 5: positive control
- Cellular proliferation data / Observations:
- No signs of systemic toxicity were noted in all groups of mice treated with Mediator SNP. There were no effects on body weights throughout the entire experiment. There was no irritation observed on any ear treated with the vehicle control or Mediator SNP at 0, 10, 25 or 50%. Well defined erythema was noted in mice from the positive control group. A stimulation index (SI) of greater than 3.0 was not observed in any of the test groups. The positive control (HCA) at 25% produced a dermal sensitization response with SI = 11.57.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Under the conditions of this assay, Mediator SNP (syringonitrile) at concentrations equal to or below 50% are not considered to be a dermal sensitizer. The response observed with the positive control validates the test system used in this study.
- Executive summary:
The objective of this study was to assess the skin sensitization potential of Mediator SNP (4-hydroxy-3,5- dimethoxybenzonitrile) after repeated topical applications.
In the preliminary screening test, 3 mice were treated with daily application of 25 μL of various dilutions of Mediator SNP to the dorsal of each ear for three consecutive days for signs of irritation and toxicity. On day 6, each site was evaluated for local reactions (edema and erythema). From these results, the concentrations to be tested in the main assay were selected with the maximum concentration equal to a 50% w/w mixture in DMF.
In the main test, groups of 5 mice each were treated with the test material at concentrations of 0, 10, 25% or 50% in DMF to the dorsal surface of each ear for three consecutive days (Days 1, 2, and 3). On day 6 (three days after the third topical application), all mice were injected via the tail vein with 250 μL of phosphate buffered saline containing3H-methyl thymidine (for a total of 20 μCi per mouse). Five hours following the administration of 3HTdR, all mice were killed and the auricular lymph nodes were drained. The lymph node cells were collected, washed and suspended in appropriate medium. DNA was then precipitated by the addition of 5 mL of 5% trichloroacetic acid (TCA). Following the overnight precipitation of DNA, the tubes were centrifuged and the supernatant discarded. The precipitate was resuspended in TCA and 3HTdR incorporation was measured by β-scintillation counting. A group of 5 mice receiving 25% HCA (alpha hexylcinnamaldehyde technical) in DMF served as positive control group.
A stimulation index (SI) is derived from each experimental group. Statistically significant increases in cell proliferation in the treated groups compared to the vehicle control group and/or SI of greater than or equal to 3.0 generally indicate a positive response.
No signs of systemic toxicity were noted in all groups of mice treated with Mediator SNP. There were no effects on body weights throughout the entire experiment. There was no irritation observed on any ear treated with the vehicle control or Mediator SNP at 0, 10, 25 or 50%. Well defined erythema was noted in mice from the positive control group. A stimulation index (SI) of greater than 3.0 was not observed in any of the test groups. The positive control (HCA) at 25% produced a dermal sensitization response with SI = 11.57.
Under the conditions of this assay, Mediator SNP at concentrations equal to or below 50% are not considered to be a dermal sensitizer. The response observed with the positive control validates the test system used in this study.
Reference
Mean DPM/Stimulation Index |
||
|
Mean DPM |
Stimulation Index |
Group 1 – Vehicle control |
567.06 |
NA |
Group 2 – 10% |
1237.16 |
2.18 |
Group 3 – 25% |
1148.08 |
2.02 |
Group 4 – 50% |
1039.03 |
1.83 |
Group 5 – Positive control |
6563.31 |
11.57 |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
The objective of this study was to assess the skin sensitization potential of Mediator SNP, 4-hydroxy-3,5-dimethoxybenzonitrile, after repeated topical applications.
In the preliminary screening test, 3 mice were treated with daily application of 25 μL of various dilutions of Mediator SNP to the dorsal of each ear for three consecutive days for signs of irritation and toxicity. On day 6, each site was evaluated for local reactions (oedema and erythema). From these results, the concentrations to be tested in the main assay were selected with the maximum concentration equal to a 50% w/w mixture in DMF.
In the main test, groups of 5 mice each were treated with the test material at concentrations of 0, 10, 25% or 50% in DMF to the dorsal surface of each ear for three consecutive days (Days 1, 2, and 3). On day 6 (three days after the third topical application), all mice were injected via the tail vein with 250 μL of phosphate buffered saline containing 3H-methyl thymidine (for a total of 20 μCi per mouse). Five hours following the administration of 3HTdR, all mice were killed and the auricular lymph nodes were drained. The lymph node cells were collected, washed and suspended in appropriate medium. DNA was then precipitated by the addition of 5 mL of 5% trichloroacetic acid (TCA). Following the overnight precipitation of DNA, the tubes were centrifuged and the supernatant discarded. The precipitate was resuspended in TCA and 3HTdR incorporation was measured by β-scintillation counting. A group of 5 mice receiving 25% HCA (alpha hexylcinnamaldehyde technical) in DMF served as positive control group.
A stimulation index (SI) is derived from each experimental group. Statistically significant increases in cell proliferation in the treated groups compared to the vehicle control group and/or SI of greater than or equal to 3.0 generally indicate a positive response.
This study was conducted to comply with the GLP regulations [40 CFR 792: US EPA GLP Standards: Toxic Substances Control Act (TSCA)] and based on the US EPA Health Effects Test Guidelines, OPPTS 870.2600.
No signs of systemic toxicity were noted in all groups of mice treated with Mediator SNP. There were no effects on body weights throughout the entire experiment. There was no irritation observed on any ear treated with the vehicle control or Mediator SNP at 0, 10, 25 or 50%. Well defined erythema was noted in mice from the positive control group. A stimulation index (SI) of greater than 3.0 was not observed in any of the test groups. The positive control (HCA) at 25% produced a dermal sensitization response with SI = 11.57.
Under the conditions of this assay, Mediator SNP is not considered to be a dermal sensitizer. The response observed with the positive control validates the test system used in this study.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)